2022
DOI: 10.1016/j.ajem.2022.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of tenecteplase versus alteplase in STEMI patients treated with ticagrelor: A cross-sectional study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 22 publications
0
6
0
Order By: Relevance
“…Zhelev et al reported that multivessel vessel disease might have an effect on the hemodynamic status [ 13 ]. Günlü and Demir reported that in case to treat with fibrinolytic agents, administration of tenecteplase in STEMI patients who received a loading dose with ticagrelor resulted in a significant reduction in major adverse cardiac events compared to alteplase [ 14 ]. In this study, patients with the NSTEMI and the Aslanger pattern tended to have a relatively high incidence of hemodynamic deterioration during revascularization procedures compared with those without the Aslanger pattern.…”
Section: Discussionmentioning
confidence: 99%
“…Zhelev et al reported that multivessel vessel disease might have an effect on the hemodynamic status [ 13 ]. Günlü and Demir reported that in case to treat with fibrinolytic agents, administration of tenecteplase in STEMI patients who received a loading dose with ticagrelor resulted in a significant reduction in major adverse cardiac events compared to alteplase [ 14 ]. In this study, patients with the NSTEMI and the Aslanger pattern tended to have a relatively high incidence of hemodynamic deterioration during revascularization procedures compared with those without the Aslanger pattern.…”
Section: Discussionmentioning
confidence: 99%
“…Crea et al reported that platelet count, high-sensitivity C-reactive protein, and serum uric acid were higher in hypertensive patients with CSF than in the control group [ 21 ]. In recent studies, the TFC was substantially higher in patients with metabolic syndrome than in those without metabolic syndrome, with greater BMI values [ 22 , 23 ]. In our research, the non-dipper group had a significantly higher BMI than the dipper group.…”
Section: Discussionmentioning
confidence: 99%
“…In a study conducted by O'Connor et al, it was reported that there were significant differences between the genders when the clinical and demographic characteristics of patients who underwent TAVR were compared [16]. Diabetes mellitus, high body mass index (BMI), previous myocardial infarction, prior percutaneous coronary intervention and low ejection fraction (EF), have been shown to be more common in male patients [17]. It has been shown that female patients have more advanced age, higher transvalvular gradient, higher pulmonary artery pressure, higher EF and smaller annulus values.…”
Section: Discussionmentioning
confidence: 99%